#pompedisease — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pompedisease, aggregated by home.social.
-
Sanofi posts positive Nexviazyme phase 3 IOPD data | SNY SEC Filing
About Sanofi Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling…
#France #FR #Europe #EU #Sanofi #Baby-COMET #biopharma #enzymereplacementtherapy #infantile-onsetPompe #labelextension #Nexviazyme #phase3trial #Pompedisease #SNY
https://www.europesays.com/france/47935/ -
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi Winthrop Industrie Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study…
#France #FR #Europe #EU #Sanofi #cardiacmuscles #diseaseprogression #musclecells #Nexviazyme #participants #phase3study #Pompedisease
https://www.europesays.com/france/46130/ -
Sanofi aims for Nexviazyme approval in younger Pompe disease patients
Sanofi’s Nexviazyme (avalglucosidase alfa) could be set for approval in younger children with Pompe disease after the Phase…
#France #FR #Europe #EU #Sanofi #diseaseprogression #invasiveventilation #neuromusculardisease #Nexviazyme #Pompedisease
https://www.europesays.com/france/44477/ -
Sanofi (ENXTPA:SAN) Faces EU Antitrust Probe As Nexviazyme Trial Delivers Positive Data
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#France #FR #Europe #EU #Sanofi #antitrustinvestigation #EuropeanCommission #EuropeanEconomicArea #fluvaccine #Pompedisease #rarediseases #SimplyWallSt
https://www.europesays.com/france/43941/ -
Sanofi (ENXTPA:SAN) Faces EU Antitrust Probe As Nexviazyme Trial Delivers Positive Data
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
#Europe #EU #antitrustinvestigation #EuropeanCommission #europeaneconomicarea #EuropeanUnion #fluvaccine #Pompedisease #rarediseases #Sanofi #SimplyWallSt
https://www.europesays.com/europe/82995/ -
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi Winthrop Industrie Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study…
#France #FR #Europe #EU #Sanofi #cardiacmuscles #diseaseprogression #musclecells #Nexviazyme #participants #phase3study #Pompedisease
https://www.europesays.com/france/43634/ -
https://www.europesays.com/ie/274996/ AskBio Announces FDA Acceptance of Investigational New Drug (IND) Application for AB-1009 Gene Therapy for Treatment of Late-Onset Pompe Disease (LOPD) #BayerAG #ClinicalTrial #Éire #EnzymeReplacement #FDAFastTrack #FoodAndDrugAdministration #GeneTherapy #Health #HealthCare #Healthcare #IE #InvestigationalNewDrug #Ireland #LOPD #OrphanDrug #PompeDisease